Overview
VSEE market data
Price History
VSEE price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.73 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.57 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.07 – $2.52 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $4 · P/B 2.28 · P/S 0.36.
Company News
Deal Dispatch: Pitney Bowes Considers Strategic Alternatives, Grant Thornton Buys CBIZ, Storj Labs BankruptcyBenzinga · Jul 31, 2026, 4:56 PM
VSee Health Announces Non-Binding LOI To Acquire Healthcare Commerce Platform Assets With Over $35M Annual Run Rate And Roughly $7M EBITDA; Terms Not DisclosedBenzinga · Jul 30, 2026, 12:46 PM
VSee Health shares are trading lower. The company announced a non-binding letter of intent for the proposed acquisition of certain healthcare technology and operating assets.Benzinga · Jul 29, 2026, 2:23 PM
Vsee Health Enters Into Non-Binding LOI For Proposed Acquisition Of Healthcare Technology And Operating Assets With $35M Plus Run Rate And $7M EBITDABenzinga · Jul 29, 2026, 12:35 PM
12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga · Jul 28, 2026, 5:06 PM
VSee Health Announces Strategic Review Of Alternatives Including Mergers And Business Combinations; Says It Is In Late-Stage Discussions With Potential PartnersBenzinga · Jul 28, 2026, 12:35 PM
VSee Health shares are trading lower after the company reaffirmed its plan to minimize shareholder dilution while maintaining financial flexibility, and its board approved a proposed 80‑for‑1 reverse split.Benzinga · Jul 22, 2026, 5:21 PM
VSee Health CEO Issues Shareholder Letter; Expects That Its iDoc Telehealth Business Can Achieve Profitability Over Next 12 MonthsBenzinga · Jul 9, 2026, 12:55 PM
VSee Health Q1 EPS $(0.05) Up From $(0.24) YoY, Sales $3.160M Down From $3.321M YoYBenzinga · May 15, 2026, 11:21 PM